search again

Nationwide rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $537,032 · 10th–90th $0$1,288,2500%20%10th90th$537,032Professionalmedian $489,779 · 10th–90th $467,735$588,8440%50%10th90th$489,779$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $851,138.04 / $1,412,537.54
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.03 / $575,439.94
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $616,595.00
Cigna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$602,559.59 / $1,348,962.88 / $1,862,087.14
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$457,088.19 / $537,031.80 / $588,843.66
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $812,830.52
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$363,078.05 / $467,735.14 / $776,247.12